首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Effects of the alpha 2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death.
【24h】

Effects of the alpha 2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death.

机译:α2-肾上腺素受体拮抗剂地昔法沙星对成年大鼠体内嗅球神经发生的影响:针对神经元死亡的选择性保护。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A dysfunction of noradrenergic mechanisms originating in the locus coeruleus has been hypothesised to be the critical factor underlying the evolution of central neurodegenerative diseases [Colpaert FC (1994) Noradrenergic mechanism Parkinson's disease: a theory. In: Noradrenergic mechanisms in Parkinson's disease (Briley M, Marien M, eds) pp 225-254. Boca Raton, FL, USA: CRC Press Inc.]. alpha(2)-Adrenoceptor antagonists, presumably in part by facilitating central noradrenergic transmission, afford neuroprotection in vivo in models of cerebral ischaemia, excitotoxicity and devascularization-induced neurodegeneration. The present study utilised the rat olfactory bulb as a model system for examining the effects of the selective alpha(2)-adrenoceptor antagonist dexefaroxan upon determinants of neurogenesis (proliferation, survival and death) in the adult brain in vivo. Cell proliferation (5-bromo-2'-deoxyuridine labelling) and cell death associated with DNA fragmentation (terminal dideoxynucleotidyl transferase-catalysed 2'-deoxyuridine-5'-triphosphate nick end-labelling assay) were quantified following a 7-day treatment with either vehicle or dexefaroxan (0.63 mg/kg i.p., three times daily), followed by a 3-day washout period. The number of terminal dideoxynucleotidyl transferase-catalysed 2'-deoxyuridine-5'-triphosphate nick end-labelling-positive nuclei in the olfactory bulb was lower in dexefaroxan-treated rats, this difference being greatest and significant in the subependymal layer (-52%). In contrast, 5-bromo-2'-deoxyuridine-immunoreactive nuclei were more numerous (+68%) in the bulbs of dexefaroxan-treated rats whilst no differences were detected in the proliferating region of the subventricular zone. Terminal dideoxynucleotidyl transferase-catalysed 2'-deoxyuridine-5'-triphosphate nick end-labelling combination with glial fibrillary acidic protein or neuronal-specific antigen immunohistochemistry revealed that terminal dideoxynucleotidyl transferase-catalysed 2'-deoxyuridine-5'-triphosphate nickend-labelling-positive nuclei were associated primarily with a neuronal cell phenotype. These findings suggest that dexefaroxan increases neuron survival in the olfactory bulb of the adult rat in vivo, putatively as a result of reducing the apoptotic fate of telencephalic stem cell progenies.
机译:已经假设起源于蓝斑轨迹的去甲肾上腺素能功能障碍是中枢神经退行性疾病发展的关键因素[Colpaert FC(1994)诺拉肾上腺素能机制帕金森氏病:一种理论。在:帕金森氏病的去甲肾上腺素能机制(Briley M,Marien M,eds),第225-254页。美国佛罗里达州博卡拉顿:CRC Press Inc.]。 alpha(2)-肾上腺素能受体拮抗剂可能部分是通过促进中央去甲肾上腺素能传递而提供的,在脑缺血,兴奋性毒性和脱血管引起的神经退行性病变模型中提供了体内神经保护作用。本研究利用大鼠嗅球作为模型系统,以检查选择性α(2)-肾上腺素能受体拮抗剂右旋苯氧呋喃对体内成年大脑神经发生(增殖,存活和死亡)决定因素的影响。经过7天的处理后,对细胞增殖(5-溴2'-脱氧尿苷标记)和与DNA片段化相关的细胞死亡(末端双脱氧核苷酸转移酶催化的2'-脱氧尿苷-5'-三磷酸缺口标记试验)进行了定量。媒介物或Dexfaroxan(0.63 mg / kg腹腔注射,每天3次),然后为期3天的洗脱期。地塞法沙坦治疗的大鼠嗅球中末端双脱氧核苷酸转移酶催化的2'-脱氧尿苷-5'-三磷酸缺口末端标记阳性核的数量较少,这种差异在表皮下层最大且显着(-52% )。相比之下,在用Dexfaroxan治疗的大鼠的球茎中,5-溴2'-脱氧尿苷-免疫反应性核的数量更多(+ 68%),而在脑室下区域的增生区域中未检测到差异。末端双脱氧核苷酸转移酶催化的2'-脱氧尿苷-5'-三磷酸缺口末端标记与胶质原纤维酸性蛋白或神经元特异性抗原免疫组化显示,末端双脱氧核苷酸转移酶催化的2'-脱氧尿苷-5'-三磷酸缺口标记末端阳性细胞核主要与神经元细胞表型有关。这些发现表明,Dexfaroxan增加了成年大鼠体内嗅球中神经元的存活,这可能是由于减少了端脑干细胞后代的凋亡命运所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号